The study population included 1546 women. In subjects with prior sPTB, the rate of recurrent sPTB <32, <35 and <37 weeks was similar for each of the qfFN concentration intervals examined with or without treatment (Table) . qfFN concentration was not associated with response to 17-P as rates of sPTB at each concentration interval were not reduced with 17-P and at 10-199 ng/ mL the sPTB rate was higher in 17-P treated women (p¼0.01,0.002, and 0.01 for <32, 35 and 37 wk, respectively). In women treated with vag P for a short cervix, sPTB rates increased as qfFN increased. In women with twins or short cervix who had a cerclage, the sPTB rate increased as qfFN increased. At qfFN concentration 10-199 ng/ mL the rate of sPTB was significantly higher in the cerclage group (p<0.001, 0.03, <0.001 for <32, 35 and 37 wk, respectively). CONCLUSION: Increasing qfFN is associated with an increasing risk of sPTB in this high-risk cohort. However, qfFN concentration is not predictive of response to either 17-P or vag-P in patients at high risk. In patients with a cervical cerclage, a qfFN 10 ng/mL appears to be associated with a failure of the cerclage to prevent sPTB. 
OBJECTIVE:
The cervical internal os (IO) contains smooth muscle which may function as a sphincter. Premature cervical failure (funneling at the IO) leading to preterm birth may be due to premature "sphincter" relaxation. Progesterone is used to treat premature cervical failure but the effects of estrogen, progesterone on human cervical smooth muscle cell (HCSMC) function is unclear. We evaluated the effects of estrogen and progesterone on HCSMC contractility and intracellular calcium flux. STUDY DESIGN: HCSMC were isolated from cervical biopsies obtained from healthy women undergoing 2 nd trimester pregnancy termination and immunostained for: estrogen (ER)/progesterone (PR) receptors, SMC markers (aSMA, SM22, desmin). HCSMC were treated overnight with serum-free media alone or decreasing concentrations (10 -5 M, 10 -7 M or 10 -9 M) of b-estradiol or progesterone and then stimulated with serum-free media/no hormones or 1uM oxytocin for 10min. F:G-actin ratio assays (indirectly measures SMC contractility) were then performed. The same experimental design was followed utilizing 1 dose of b-estradiol or progesterone (10 -7 M) and calcium flux assays were performed. Experiments were repeated at least twice using HCSMC from 6 women. Statistical analysis included Student's t-test and ANOVA.
RESULTS: Primary HCSMC express ER, PR and mature SMC markers. b-estradiol significantly increases HCSMC contractility and enhances oxytocin-induced contractility (increases F:G actin ratios). Progesterone significantly reduces oxytocin-induced HCSMC contractility (decreases F:G actin ratios, Fig 1) . Results were similar regardless of hormone concentration. Intracellular calcium levels were increased by oxytocin and decreased by progesterone. bestradiol did not increase calcium levels compared to treatment with oxytocin alone (Fig. 2) .
CONCLUSION: b-estradiol increases and progesterone decreases HCSMC contractility. Progesterone likely decreases contractility through alterations in intracellular calcium flux. If a smooth muscle sphincter exists at the IO, further studies are needed to comprehend the effect of pregnancy hormones, specifically progesterone, on cervical function in pregnancy. This study highlights the importance of performing studies which mimic the pregnant hormonal environment to accurately understand normal and abnormal cervical function in pregnancy.
558 Short cervical length in low risk women: how many will become dilated before 24 weeks? OBJECTIVE: It has been well established that short cervical length (CL) is associated with an increased risk of spontaneous preterm birth (SPTB). In women without a history of SPTB and a short CL found incidentally on ultrasound, previous studies have shown that cerclage is not associated with improved outcomes. Women with a dilated cervix, however, may benefit from cerclage. It is not well understood which women with a short CL will ultimately become dilated. We sought to determine what proportion of women with a short CL without a history of SPTB will ultimately be dilated at <24 weeks and thus be cerclage candidates. STUDY DESIGN: This was a retrospective cohort study of women with singleton pregnancies with short CL (25mm) between 16-22 weeks' gestational age (GA) diagnosed at a single maternal-fetal medicine ultrasound unit between 2011 and May 2018. We included women without a history of SPTB. We routinely perform ultrasounds on women at 16 and 20 weeks GA and image the cervix in all women transabdominally. If the CL was suspected to be short, transvaginal imaging was performed. We routinely follow women with a short CL with serial CL's, and speculum exams for those with Poster Session III 
